Bayer's Cash Flow Guidance Looks Soft -- Market Talk

Dow Jones
2025/03/05

0830 GMT - Bayer's fourth-quarter results are slightly ahead of expectations and guidance is in line with consensus, but the free cash flow outlook is soft, Jefferies analysts write. Bayer reported fourth-quarter adjusted Ebitda of 2.35 billion euros versus consensus at 2.27 billion euros while free cash flow also beat views. Full-year 2025 guidance for Ebitda of 9.3 billion-9.8 billion euros at closing exchange rates compares to consensus at 9.4 billion euros while core EPS guidance is also ahead. But free cash-flow guidance of 1.3 billion-2.3 billion euros is below the 2.8 billion euros expected by consensus. "We expect a small negative response." Shares rise 1.5% after initially dropping as much as 2.5% at the open. (dominic.chopping@wsj.com)

 

(END) Dow Jones Newswires

March 05, 2025 03:30 ET (08:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10